Remove 2011 Remove Biochemical Assays Remove Cell Based Assays Remove Pharmaceuticals
article thumbnail

Article FDA Thank You Draft guidance on potency assays for CGT products garners extensive stakeholder input

Agency IQ

Draft guidance on potency assays for CGT products garners extensive stakeholder input Late last year, the FDA published a draft update to its 2011 guidance on potency assays for cell and gene therapy products, unveiling a major shift in approach to the issue.

article thumbnail

Transforming high-throughput screening with mass spectrometry

Drug Discovery World

HTS is widely used by pharmaceutical companies to identify compounds (or ‘hits’) that show pharmacological activity, which are used as starting points to optimise medicines during the drug discovery process. Trapped ion mobility spectrometry: Improving the specificity of MALDI-MS-based HTS . Castellino, M.R. Groseclose and D.